Hypertension (HTN) remains a principal cause of premature death worldwide. The goal of this learning activity is to provide doctors with a comprehensive review of renal denervation therapy (RDN) and its role in improving blood pressure control in patients with HTN. Upon completing this module, participants will have a better understanding of the following aspects:
Clin Assoc Prof Chin Chee Tang
Senior Consultant Cardiologist
National Heart Centre Singapore
Who should participate:
Please watch the video before attempting the assessment questions.
Terms & Conditions:
To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.